However, the remaining 25% of patients have other associated genetic mutations including ACVLR1, ENG, SMAD4, and BMP9 (also known as GDF2), of which the first three are also associated with HHT [17, 18]. Here, SMAD4 is linked to hereditary hemorrhagic telangiectasia.